Graves' dermopathy: does octreotide scintigraphy predict the response to octreotide treatment?
We report on three patients with severe Graves' dermopathy who were treated with octreotide despite a negative octreotide scintigraphy. One patient showed a complete recovery while two others had a partial response. In contrast to active Graves' ophthalmopathy, an octreotide scintigraphy appears not to be useful for pretreatment identification of patients with Graves' dermopathy who are likely to respond to octreotide treatment.
Kuyvenhoven
J P
JP
Department of Endocrinology, University Hospital Leiden, The Netherlands.
van der Pijl
J W
JW
Goslings
B M
BM
Wiersinga
W M
WM
D000328:Adult; D000368:Aged; D005260:Female; D006111:Graves Disease / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009230:Myxedema / Q000000981:diagnostic imaging / Q000188:drug therapy; D015282:Octreotide / Q000627:therapeutic use*; D011877:Radionuclide Imaging; D012871:Skin Diseases / Q000000981:diagnostic imaging* / Q000188:drug therapy*
D006728:Hormones; D015282:Octreotide